Financials in USD. Standardized financial statements.
A compact view of how SomaLogic, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Revenue? | $97.67M | $81.63M | $55.89M | $32.19M |
| Revenue Growth? | +19.7% | +46.1% | +73.6% | 0.0% |
| Cost of Revenue? | $43.36M | $33.46M | $22.61M | $49.72M |
| Gross Profit? | $54.30M | $48.16M | $33.27M | -$17.53M |
| Gross Margin? | +55.6% | +59.0% | +59.5% | -54.5% |
| Operating Expenses? | $230.06M | $121.47M | $67.63M | $33.99M |
| Operating Income? | -$175.76M | -$73.30M | -$34.36M | -$50.96M |
| EBITDA? | -$175.76M | -$86.00M | -$31.53M | -$47.80M |
| Income Before Tax | -$109.87M | -$87.55M | -$53.02M | -$57.00M |
| Income Tax Expense | -$717,000 | -$1.25M | $18.34M | $0 |
| Net Income? | -$109.16M | -$86.30M | -$71.35M | -$57.00M |
| EPS? | $-0.59 | $-0.63 | $-0.39 | $-0.31 |
| Diluted EPS? | $-0.59 | $-0.63 | $-0.39 | $-0.31 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality